Dreem
7
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Combating Alzheimer's Through Sleep and Exercise
Role: collaborator
Sleep Quality Evolution: Dreem Under CPAP
Role: collaborator
Robustness and Usability of the Dreem 3 System for at Home Sleep Monitoring in an Insomnia Population.
Role: lead
Performance Evaluation of the Dreem 3 System for Sleep Assessment in Patients With Insomnia
Role: lead
Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults
Role: lead
Comparison of Dreem to Clinical PSG for Sleep Monitoring in Apnea Patients
Role: lead
Effects of Synchronised Auditory Stimulations of the Sleep Slow Oscillation on Deep Sleep Quality
Role: lead
All 7 trials loaded